Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 0904-6902

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 0904-6902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

78d772ca 8f18 4dc6 985d A531fa15d494 00

This is a package of Raloxifene Hydrochloride tablets, USP in Unit Dose packaging with NDC 0904-6902-04. It is a prescription medication that should be dispensed with a medication guide by a pharmacist. The usual adult dosage is not provided in the text. It is stored at room temperature between 15-30°C (59-86°F) and kept out of the reach of children. The package is tamper-evident and child-resistant. The manufacturer is MAJOR and distributed by ORPHEUS THERAPEUTICS INC. The provided text does not have any non-English characters.*

FDA Label Image

Figure 1: Total Hip Bone Mineral Density Mean Percentage Change From Baseline (Raloxifene Pi 02v1)

FDA Label Image

Chemical Structure (Raloxifene Pi)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.